The Provisio Medical Physician Advisory Board (PAB) is a multidisciplinary group of physicians, representative of our diverse customer base. Our PAB will serve as strategic partners who will provide input and feedback on the product development decisions, outcome focused clinical studies and patient therapy focused synergistic applications of our technologies.
David Deaton, MD, FACS
Dr. Deaton, a native of Hickory NC, graduated from Haverford College and received his medical degree from Duke University in 1985. He went on to the Hospital of University of Pennsylvania for surgical residency and research fellowship followed by a vascular surgery fellowship at UCLA. He joined the faculty of East Carolina University in 1995 and performed the first endovascular aortic aneurysm repair and the first endovascular thoracic aortic aneurysm repair during his tenure there. After leaving ECU he joined the faculty of Georgetown University in Washington DC where he founded the endovascular program there as well as the vascular lab and clinical research program. He also served as a staff surgeon at the Cleveland Clinic in a part-time role when he was also serving as the Chief Medical Officer of Endologix, Inc. In addition to his clinical career, Dr. Deaton has served as an officer of numerous medical societies to include the Peripheral Vascular Surgery Society, the Society of Vascular Surgery and the Chesapeake Vascular Society. He has pioneered multiple endovascular aortic and lower extremity revascularization procedures and devices as an investigator and and a named inventor on 15 patents. Dr. Deaton has served as a primary clinical expert for FDA panels, CMS reimbursement panels and ICD coding hearings. He has been an invited speaker in over 190 conferences throughout the US, Europe and Asia and has authored numerous book chapters and peer-reviewed publications. He has been a featured expert on the CNN network and other media outlets during both his tenure at ECU and while at Georgetown University. Dr. Deaton’s clinical interests span the breadth of vascular diagnoses using both open surgical reconstructive techniques and minimally invasive endovascular therapies.
Zola N’Dandu, MD FACC, FSCAI
Dr. N’Dandu studied at Old Dominion University in Norfolk, VA then earned his medical degree from Eastern Virginia Medical School. He further trained at Ochsner Health System in New Orleans in Internal Medicine, Cardiology, and Interventional Cardiology with a dedicated focus in Peripheral Vascular Disease. He recently transitioned to St. Augustine, Florida, continuing his mission to make a meaningful impact in cardiology and peripheral vascular disease with contributions to the advancements in peripheral arterial disease (PAD) research. His commitment lies in PAD, with a specific emphasis on critical limb ischemia. In the quest to prevent unnecessary amputations, his career interest and endeavors focus on enhancing infrapopliteal and inframalleolar interventions, striving to redefine what are considered limited options for patients facing amputations.
Mahmood Razavi, MD, FSIR, FSVM
Dr. Razavi is the Director of the Department of Clinical Trials at St Joseph Heart and Vascular Center, Orange, California. He received his medical degree from the University of Southern California and completed his residency training at UCLA, followed by two subspecialty fellowships at Stanford University and UCLA. He has been on the academic faculties of UCLA and Stanford University Medical Schools. To date, he has authored or co-authored over 350 scientific publications, abstracts, and book chapters, and has been the recipient of many honors and awards from multiple professional medical societies. He has been the recipient of several industry, institutional and federal grants and has given over 600 invited lectures in national and international scientific meetings. Dr. Razavi is the founder or co-founder of 6 medical device companies, and past Chief Medical Officer of 4 early-stage companies focused on development and commercialization of medical devices. He is a current or prior member of scientific/strategic advisory boards of 42 start-up medical companies with 17 exit/IPOs to date. He has been national or global Principal Investigator of 13 sponsored clinical trials and the site PI of another 50 multicenter studies, and steering committee chair or member of 9 industry or NIH sponsored clinical trials. Dr. Razavi was past Editor in Chief of Techniques in Vascular & Interventional Radiology, past Associate Editor of the Journal of Vascular & Interventional Radiology and past or present member of the Editorial Boards of the Journals of Endovascular Therapy, Critical Limb Ischemia and Transplantation Sciences, and Endovascular Today.
Peter Schneider, MD, FACS
Dr. Schneider is Professor of Surgery at University of California San Francisco. Dr. Schneider received his MD from the Johns Hopkins School of Medicine and completed his vascular surgery fellowship at the University of California San Francisco. Dr. Schneider was the founding member and Chief of Vascular Surgery at Kaiser Permanente in Hawaii from 1994-2018. He is a Distinguished Fellow of the Society for Vascular Surgery and past president of Western Vascular Society and Vascular and Interventional Advances (VIVA). He has been invited to numerous visiting professorships, served as director, faculty or course director for many specialty courses and performed revascularization procedures in more than a dozen countries. He authored “Endovascular Skills,” now in its 4th edition and has co-authored three other books on various aspects of vascular disease.
Dr. Bret Wiechmann
Dr. Wiechmann has been in private practice for 26 years with Vascular & Interventional Physicians in Gainesville, Florida, USA, with a particular interest in peripheral arterial disease & critical limb ischemia, abdominal aortic aneurysms, carotid intervention, and venous disease. He has been elected a Fellow in 4 different medical associations, including the Society of Interventional Radiology, the Society of Vascular Medicine, the American Heart Association, and the Outpatient Endovascular & Interventional Society (OEIS) and has served in many leadership roles in these societies. Dr. Wiechmann is a founding member of the Outpatient Endovascular & Interventional Society (OEIS), serves on the Board, and is immediate past-President of OEIS. He has given over 230 invited lectures, has been principal investigator in numerous clinical trials in peripheral vascular interventions, carotid stenting, medical therapy for peripheral arterial disease (PAD), and stem cell therapy for critical limb ischemia, and is lead or co-author on 30 peer-reviewed articles.